Related Experiment Video
Updated: Jun 4, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for
Felipe Cabezas1, Jonathan Lagos, Carlos Céspedes
1Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Background:
Megalin is a large endocytic receptor with relevant functions during development and adult life. It is expressed at the apical surface of several epithelial cell types, including proximal tubule cells (PTCs) in the kidney, where it internalizes apolipoproteins, vitamins and hormones with their corresponding carrier proteins and signaling molecules. Despite the important physiological roles of megalin little is known about the regulation of its expression. By analyzing the human megalin promoter, we found three response elements for the peroxisomal proliferator-activated receptor (PPAR). The objective of this study was to test whether megalin expression is regulated by the PPARs.
Methodology/Principal Findings:
Treatment of epithelial cell lines with PPARα or PPARγ ligands increased megalin mRNA and protein expression. The stimulation of megalin mRNA expression was blocked by the addition of specific PPARα or PPARγ antagonists. Furthermore, PPAR bound to three PPAR response elements located in the megalin promoter, as shown by EMSA, and PPARα and its agonist activated a luciferase construct containing a portion of the megalin promoter and the first response element. Accordingly, the activation of PPARα and PPARγ enhanced megalin expression in mouse kidney. As previously observed, high concentrations of bovine serum albumin (BSA) decreased megalin in PTCs in vitro; however, PTCs pretreated with PPARα and PPARγ agonists avoided this BSA-mediated reduction of megalin expression. Finally, we found that megalin expression was significantly inhibited in the PTCs of rats that were injected with BSA to induce tubulointerstitial damage and proteinuria. Treatment of these rats with PPARγ agonists counteracted the reduction in megalin expression and the proteinuria induced by BSA.
Conclusions:
PPARα/γ and their agonists positively control megalin expression. This regulation could have an important impact on several megalin-mediated physiological processes and on pathophysiologies such as chronic kidney disease associated with diabetes and hypertension, in which megalin expression is impaired.
Insights
Peroxisome proliferator-activated receptors (PPARs) positively regulate megalin expression, a key endocytic receptor in the kidney. This finding offers potential therapeutic strategies for kidney diseases where megalin function is impaired.
Area of Science:
- Molecular Biology
- Cell Biology
- Renal Physiology
Background:
- Megalin is a crucial endocytic receptor in kidney proximal tubule cells (PTCs), vital for development and adult physiology.
- Megalin internalizes various molecules, including apolipoproteins, vitamins, and hormones, via carrier proteins.
- Regulation of megalin expression remains largely unknown despite its significant roles.
Purpose of the Study:
- To investigate whether peroxisome proliferator-activated receptors (PPARs) regulate megalin expression.
- To identify response elements for PPARs within the human megalin promoter.
Main Methods:
- Analysis of the human megalin promoter for PPAR response elements.
- Treatment of epithelial cell lines and mouse kidneys with PPAR ligands and antagonists.
- Electrophoretic Mobility Shift Assay (EMSA) to confirm PPAR binding to the promoter.
- Luciferase reporter assays to assess promoter activity.
- In vitro studies using bovine serum albumin (BSA) to mimic kidney damage.
- In vivo studies in rats with BSA-induced kidney injury.
Main Results:
- PPARα and PPARγ ligands significantly increased megalin mRNA and protein expression in epithelial cells.
- PPAR binding to response elements in the megalin promoter was confirmed.
- PPAR activation enhanced megalin expression in mouse kidneys.
- PPAR agonists protected against BSA-induced reduction of megalin expression in PTCs.
- PPARγ agonist treatment counteracted BSA-induced megalin downregulation and proteinuria in rats.
Conclusions:
- PPARα and PPARγ agonists positively regulate megalin expression.
- This regulatory mechanism is significant for physiological processes mediated by megalin.
- Understanding this regulation could impact treatments for kidney diseases like diabetic nephropathy and hypertensive nephropathy, where megalin expression is often compromised.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Peroxisomes
PI3K/mTOR/AKT Signaling Pathway
Global Regulatory Systems
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Cell Specific Gene Expression